Literature DB >> 15752162

The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood.

Stefan Runkel1, Hannelore Haubelt, Walter Hitzler, Peter Hellstern.   

Abstract

BACKGROUND: There exists a current lack of information about the composition of the different types of plasma. No direct comparisons between apheresis plasma (AP) and recovered plasma (RP) derived from in-line-filtered whole blood (WB) have been published to date. STUDY DESIGN AND METHODS: Sixty AP units, 100 RP units from in-line-filtered WB held for 3 hours at 20 degrees C between donation and freezing, and an additional 100 RP units held for 15 hours at 20 degrees C before freezing were analyzed for coagulation factors and inhibitors, total protein, immunoglobulin G (IgG), and hemostasis and proteolysis activation markers. The influence of twice freezing and thawing on clotting factors V, VIII, and XI was also examined.
RESULTS: AP contains substantially greater activities of factor (F) V, FVIII, F IX, and FXI than RP frozen within 3 hours after WB donation. Prolonged holding of RP at 20 degrees C for more than 15 hours caused an additional reduction in FVIII, FXI, and protein S activities. Significantly greater levels of prothrombin fragments 1 and 2, platelet factor 4, and neutrophil elastase were found in RP compared with AP. IgG was lower in AP compared with RP. Twice freezing and thawing caused a marked drop in FV, FVIII, and FXI activity.
CONCLUSION: Higher FVIII and F IX potencies in AP compared with RP can be expected to result in greater yields when used for purification of these clotting factors. AP is presumably more efficient than RP for treating coagulopathies. RP, however, may contain higher IgG levels than AP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752162     DOI: 10.1111/j.1537-2995.2005.04276.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  10 in total

1.  Markers of Blood Cell Activation and Complement Activation in Factor VIII and von Willebrand Factor Concentrates.

Authors:  Martin F Brodde; Beate E Kehrel
Journal:  Transfus Med Hemother       Date:  2010-07-14       Impact factor: 3.747

2.  Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

3.  4 Plasma for Therapeutic Use.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

4.  The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma.

Authors:  Peter Hellstern; Bjarte G Solheim
Journal:  Transfus Med Hemother       Date:  2011-01-17       Impact factor: 3.747

5.  Procoagulant impact of the plasmapheresis procedure on coagulation state of collected plasma.

Authors:  Stepan Surov; Ruzanna Ovsepyan; Igor Vysochin; Elena Kobzeva; Valeriy Khvatov; Mikhail Panteleev; Tatiana Vuimo
Journal:  Blood Transfus       Date:  2015-07-09       Impact factor: 3.443

6.  Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations.

Authors:  R Laub; S Baurin; D Timmerman; T Branckaert; P Strengers
Journal:  Vox Sang       Date:  2010-10       Impact factor: 2.144

7.  Biochemical and cellular markers differentiate recovered, in-line filtered plasma, and plasma obtained by apheresis methods.

Authors:  Jürgen Siekmann; Alfred Weber; Christoph Bauer; Peter L Turecek
Journal:  Vox Sang       Date:  2021-06-10       Impact factor: 2.996

Review 8.  Quality Assessment of Established and Emerging Blood Components for Transfusion.

Authors:  Jason P Acker; Denese C Marks; William P Sheffield
Journal:  J Blood Transfus       Date:  2016-12-14

9.  Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units.

Authors:  Michal Bubinski; Agnieszka Gronowska; Pawel Szykula; Kamila Kluska; Ilona Kuleta; Emilia Ciesielska; Marcus Picard-Maureau; Elzbieta Lachert
Journal:  Transfus Med       Date:  2021-03-08       Impact factor: 2.019

10.  Plasma Transfusion Practice in Adult Surgical Patients: Systematic Review of the Literature.

Authors:  Elisabeth Hannah Adam; Dania Fischer
Journal:  Transfus Med Hemother       Date:  2020-09-18       Impact factor: 3.747

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.